denosumab-dssb 60 MG per 1 ML Prefilled Syringe

RxCUI
2725502
RxNorm name
denosumab-dssb 60 MG per 1 ML Prefilled Syringe
Display name
denosumab-dssb 60 MG per 1 ML Prefilled Syringe
Full name
denosumab-dssb 60 MG per 1 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761392Ospomyvdenosumab-dssb351(k) InterchangeableRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OSPOMYVDENOSUMABCordavis Limitede1d80a82-de52-4a34-9df3-609e50667ffb2025-11-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2725502

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e1d80a82-de52-4a34-9df3-609e50667ffbdenosumab-dssb 60 MG in 1 ML Prefilled Syringe [PSN] · 1 ML denosumab-dssb 60 MG/ML Prefilled Syringe [SCD] · denosumab-dssb 60 MG per 1 ML Prefilled Syringe [SY]36These highlights do not include all the information needed to use OSPOMYV safely and effectively. See full prescribing information for OSPOMYV. OSPOMYV™ (denosumab-dssb) injection, for subcutaneous use Initial U.S. Approval: 2025 OSPOMYV (denosumab-dssb) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between20251111